Table 2.

Potential predictors of in-hospital gout flares. Values are n (%) or mean ± SD unless otherwise specified.

PredictorsValue*OR (95% CI)
Diagnosis year 2009–2010 (vs 1989–1992)306 (56)1.47 (0.65–3.35)
Age at gout diagnosis, yrs, per 10-yr increase59.7 ± 17.31.15 (0.86–1.55)
Male sex312 (73)1.08 (0.46–2.56)
Time since most recent flare prior to hospitalization, per 1-year increase3.4 ± 4.00.87 (0.74–1.02)
No. flares prior to hospitalization2.7 ± 2.21.04 (0.88–1.23)
> 1 joint affected at gout diagnosis861 (12)1.75 (0.60–5.06)
Joint other than 1st MTP affected at gout diagnosis253 (36)1.31 (0.57–3.03)
Had ULT at hospital admission211 (30)0.36 (0.11–1.01)
Started ULT within 3 months prior to hospitalization27 (8)2.82 (0.71–11.25)
ULT discontinued at/during hospitalization18 (4)0.86 (0.11–6.83)
ICU stay during hospitalization61 (13)1.24 (0.45–3.42)
Taking diuretics during hospitalization248 (55)1.46 (0.64–3.30)
Kidney disease325 (46)0.91 (0.40–2.06)
Serum uric acid level at gout diagnosis, mg/dl8.7 ± 1.91.40 (1.11–1.77)
BMI at hospital admission, kg/m229.2 ± 7.80.99 (0.94–1.05)
Obesity at hospital admission, BMI ≥ 30 kg/m2244 (37)0.80 (0.33–1.96)
Obesity at hospital admission, BMI ≥ 35 kg/m2120 (18)1.43 (0.52–3.90)
Morbid obesity at hospital admission, BMI ≥ 40 kg/m263 (10)1.97 (0.61–6.39)
  • * Values based on no. hospitalizations, not no. unique patients. ULT: urate-lowering therapy; MTP: metatarsophalangeal joint; ICU: intensive care unit; BMI: body mass index.